-
Communication | Marseille (13000)
2019 - 2020
- Area : ½ France South
- Products: Acalabrutinib (CLL)
- Activity :
Ensure competitive, scientific and regional environment monitoring
Active listening & uncovering HCP’s current thinking (KOL, emerging leaders, user teams)
Identify insights and develop opportunities for scientific partnerships in accordance with company's strategy and the rules of good use to embrace patient centric healthcare
Communication and Medical Information: HCP staff presentation
Detection and implementation of clinical study programs
Lead scientific and medical meetings with high added value
During launches and throughout the product’s life cycle, provide expertise in the field and contribute to the training of sales forces
-
M'y Tomorrows
- Medical Science Liaison
Communication | Marseille (13000)
2018 - 2018
Medical Scientific Liaison-Rare Disease
Area : ½ France South
Products:
ENDARI ® (Sickle cell disease)- Early Access Program
MARQIBO ® (Acute Lymphoblastic Leukemia)- Early Access Program
T CAR cell therapy (LAL & Lymphoma) - Early Access Program
-
CHUGAI Pharma
- Medical representative in Onco-Haematology
Communication |
2008 - 2017
PRODUCTS :
GRANOCYTE (lenograstim ; r-Hu-G-CSF);
XELODA (capecitabine)
ACTIVITY :
Medical Communication : Face to Face présentation : STAFF (35/year)
Competitive monitoring of regional environnement
Scientific & Health econony monitoring;
Medical Society Congress attendance (ESMO; ASCO; EBMT ; St Gallen)
KOL Target Qualification , Medical Action plan
Reporting C.R.M.
Professionnal Relations
Organisation of Ad Hoc meeting (ETP,
Review analysis training for internhip
Pharmacovigilance ;Phase IV Clinical trial follow
-
CHUGAI Pharma
- Key Account Manager
Commercial | Marseille
2001 - 2008
Key Account Manager
Area : France (11/2004 -12/2008)
Area : ½ France East (01/2003 - 11/2004) - ½ France West (08/2001 - 01/2003)
PRODUCTS :
- GRANOCYTE ® (Chemotherapy Induced Neutropenia);
- XELODA ® (Breast; G.I.)
Activity :
Commercial Strategy: Proposal and Implementation
Public Procurement Management & Negotiation of Private Hospitalisation
Intra-company meetings facilitation: communication elements
Project management: tailored company event (4 days Clinical Pharmacy training session)
Pharmacist meetings (Int., Nat., Regional): client guests accompaniement. (SFPO, SFPC, APHIF, APHO, APHBFC, ACOPHRA, ADPHSO, APHROC, APHAL, APPHUS, GERHNU, PHAST, GERPAC, LAROPHA, APHOSA)
-
CHUGAI Pharma
- Medical representative in Onco-Haematology
Communication |
2000 - 2001
PRODUCTS :
GRANOCYTE (lenograstim ; r-Hu-G-CSF);
XELODA (capecitabine)
ACTIVITY :
Medical Communication : Face to Face présentation : STAFF (35/year)
Competitive monitoring of regional environnement
Scientific & Health econony monitoring;
Medical Society Congress attendance (ESMO; ASCO; EBMT ; St Gallen)
KOL Target Qualification , Medical Action plan
Reporting C.R.M.
Professionnal Relations
Organisation of Ad Hoc meeting (ETP,
Review analysis training for internhip
Pharmacovigilance ;Phase IV Clinical trial follow
-
Janssen Pharmaceutica
- Medical representatve in onco-haematology
Commercial | Paris (75000)
1999 - 2000
AREA : Departments 78-28-91-45-77
PRODUCTS : EPREX (epoetin alpha = r-Hu-EPO) ; SPORANOX (itraconazole)
ACTIVITY :
Medical Communication : Face to Face présentation : STAFF (35/year)
Competitive monitoring of regional environnement
Scientific & Health econony monitoring;
Medical Society Congress attendance (ESMO; ASCO; EBMT ; St Gallen)
KOL Target Qualification , Medical Action plan
Reporting C.R.M.
Professionnal Relations
Organisation of Ad Hoc meeting (ETP,
Review analysis training for internhip
Pharmacovigilance ;Phase IV Clinical trial follow
-
Chiron Pcs
- Medical representatve in onco-haematology
Communication | LES PONTS DE CE
1998 - 1998
AREA : Paris & Suburbs
PRODUICS : PROLEUKIN ( r-Hu-IL 2) ; CARDIOXANE (dexrazoxane)
-
Air Products & Chemicals
- Medical representative
Commercial | Lille (59000)
1995 - 1997
AREA: Departements 59 - 62 - 02 - 08
PRODUCTS : Medical gaz (Oxygen, Nitrous Protoxyde) & associates services (oxygenothérapy)
